These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 21167241

  • 1. The CCK(-like) receptor in the animal kingdom: functions, evolution and structures.
    Staljanssens D, Azari EK, Christiaens O, Beaufays J, Lins L, Van Camp J, Smagghe G.
    Peptides; 2011 Mar; 32(3):607-19. PubMed ID: 21167241
    [Abstract] [Full Text] [Related]

  • 2. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R.
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [Abstract] [Full Text] [Related]

  • 3. CCK(-like) and receptors: structure and phylogeny in a comparative perspective.
    Yu N, Smagghe G.
    Gen Comp Endocrinol; 2014 Dec 01; 209():74-81. PubMed ID: 24842717
    [Abstract] [Full Text] [Related]

  • 4. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A, Lutz J, Escrieut C, Fourmy D, van Neuren AS, Müller G, Schafferhans A, Klebe G, Moroder L.
    Biopolymers; 2014 Dec 01; 56(2):55-76. PubMed ID: 11592053
    [Abstract] [Full Text] [Related]

  • 5. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD.
    Protein Sci; 1999 Nov 01; 8(11):2347-54. PubMed ID: 10595537
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin and learning and memory processes.
    Hadjiivanova C, Belcheva S, Belcheva I.
    Acta Physiol Pharmacol Bulg; 2003 Nov 01; 27(2-3):83-8. PubMed ID: 14570153
    [Abstract] [Full Text] [Related]

  • 7. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis).
    Oliver AS, Vigna SR.
    Gen Comp Endocrinol; 1997 Jan 01; 105(1):91-101. PubMed ID: 9000471
    [Abstract] [Full Text] [Related]

  • 8. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 01; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
    Foucaud M, Archer-Lahlou E, Marco E, Tikhonova IG, Maigret B, Escrieut C, Langer I, Fourmy D.
    Regul Pept; 2008 Jan 10; 145(1-3):17-23. PubMed ID: 17961734
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
    Hadac EM, Ji Z, Pinon DI, Henne RM, Lybrand TP, Miller LJ.
    J Med Chem; 1999 Jun 17; 42(12):2105-11. PubMed ID: 10377216
    [Abstract] [Full Text] [Related]

  • 14. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.
    J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Applicability of CCK receptor antagonists in physiologic and therapeutic studies].
    Heintges T, Niederau C.
    Z Gastroenterol; 1992 May 27; 30(5):337-43. PubMed ID: 1632116
    [Abstract] [Full Text] [Related]

  • 17. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 27; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 18. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G, Kisfalvi K, Pelosini I, D'Amato M, Scarpignato C.
    Br J Pharmacol; 1998 Jun 27; 124(3):435-40. PubMed ID: 9647465
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function.
    Tachibana I, Kanagawa K, Yamamoto Y, Otsuki M.
    J Pharmacol Exp Ther; 1996 Dec 27; 279(3):1404-12. PubMed ID: 8968365
    [Abstract] [Full Text] [Related]

  • 20. Neurobiology of cholecystokinin.
    Moran TH, Schwartz GJ.
    Crit Rev Neurobiol; 1994 Dec 27; 9(1):1-28. PubMed ID: 8828002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.